130 related articles for article (PubMed ID: 10544118)
21. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.
Ghosh SK; Roy-Burman P; Faller DV
J Virol; 2000 Oct; 74(20):9742-8. PubMed ID: 11000248
[TBL] [Abstract][Full Text] [Related]
22. Rapid detection of feline leukemia virus provirus integration into feline genomic DNA.
Cattori V; Tandon R; Pepin A; Lutz H; Hofmann-Lehmann R
Mol Cell Probes; 2006; 20(3-4):172-81. PubMed ID: 16488115
[TBL] [Abstract][Full Text] [Related]
23. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions.
Berry BT; Ghosh AK; Kumar DV; Spodick DA; Roy-Burman P
J Virol; 1988 Oct; 62(10):3631-41. PubMed ID: 2843665
[TBL] [Abstract][Full Text] [Related]
24. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats.
Ellis JA; Jackson ML; Bartsch RC; McGill LG; Martin KM; Trask BR; Haines DM
J Am Vet Med Assoc; 1996 Aug; 209(4):767-71. PubMed ID: 8756876
[TBL] [Abstract][Full Text] [Related]
25. Absolute quantitation of feline leukemia virus proviral DNA and viral RNA loads by TaqMan real-time PCR and RT-PCR.
Cattori V; Hofmann-Lehmann R
Methods Mol Biol; 2008; 429():73-87. PubMed ID: 18695960
[TBL] [Abstract][Full Text] [Related]
26. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
Mertz JA; Mustafa F; Meyers S; Dudley JP
J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
[TBL] [Abstract][Full Text] [Related]
27. HNF-3beta is a critical factor for the expression of the Jaagsiekte sheep retrovirus long terminal repeat in type II pneumocytes but not in Clara cells.
McGee-Estrada K; Palmarini M; Fan H
Virology; 2002 Jan; 292(1):87-97. PubMed ID: 11878911
[TBL] [Abstract][Full Text] [Related]
28. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat.
Hisasue M; Nagashima N; Nishigaki K; Fukuzawa I; Ura S; Katae H; Tsuchiya R; Yamada T; Hasegawa A; Tsujimoto H
Int J Cancer; 2009 Mar; 124(5):1133-41. PubMed ID: 19035458
[TBL] [Abstract][Full Text] [Related]
29. Host cell range of T-lymphotropic feline leukemia virus in vitro.
Shojima T; Nakata R; Miyazawa T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
[TBL] [Abstract][Full Text] [Related]
30. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
[TBL] [Abstract][Full Text] [Related]
31. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets.
Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction.
Tandon R; Cattori V; Gomes-Keller MA; Meli ML; Golder MC; Lutz H; Hofmann-Lehmann R
J Virol Methods; 2005 Dec; 130(1-2):124-32. PubMed ID: 16054243
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
[TBL] [Abstract][Full Text] [Related]
34. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
Pantginis J; Beaty RM; Levy LS; Lenz J
J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
[TBL] [Abstract][Full Text] [Related]
35. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
Chandhasin C; Coan PN; Levy LS
J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B.
Phipps AJ; Hayes KA; Al-dubaib M; Roy-Burman P; Mathes LE
Virology; 2000 Nov; 277(1):40-7. PubMed ID: 11062034
[TBL] [Abstract][Full Text] [Related]
37. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Abujamra AL; Faller DV; Ghosh SK
Virology; 2003 May; 309(2):294-305. PubMed ID: 12758176
[TBL] [Abstract][Full Text] [Related]
38. Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases.
Operario DJ; Reynolds HM; Kim B
Virology; 2005 Apr; 335(1):106-21. PubMed ID: 15823610
[TBL] [Abstract][Full Text] [Related]
39. Presence of a Shared 5'-Leader Sequence in Ancestral Human and Mammalian Retroviruses and Its Transduction into Feline Leukemia Virus.
Kawasaki J; Kawamura M; Ohsato Y; Ito J; Nishigaki K
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768854
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide sequence of the splice junction of feline leukemia virus envelope mRNA.
Papenhausen MD; Overbaugh J
Virology; 1993 Aug; 195(2):804-7. PubMed ID: 8393248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
